• Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

RCUS:BB

40.7050 EUR 0.6550 1.64%

As of 03:39:37 ET on 07/11/2014.

Snapshot for Arseus NV (RCUS)

Open: 40.1000 Day's Range: 40.1000 - 40.7300 Volume: 3,893
Previous Close: 40.0500 52wk Range: 17.6100 - 43.9400 1-Yr Rtn: +111.15%

Stock Chart for RCUS

No chart data available.
  • RCUS:BB 40.6850
  • 1D
  • 1M
  • 1Y
40.0500
Interactive RCUS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RCUS

Current P/E Ratio (ttm) 28.0802
Estimated P/E(12/2014) 19.5652
Relative P/E vs. BEL20 0.5872
Earnings Per Share (EUR) (ttm) 1.4263
Est. EPS (EUR) (12/2014) 2.0470
Est. PEG Ratio -
Market Cap (M EUR) 1,258.83
Shares Outstanding (M) 31.43
30 Day Average Volume 83,122
Price/Book (mrq) 2.6235
Price/Sale (ttm) 3.2184
Dividend Indicated Gross Yield 1.80%
Cash Dividend (EUR) 0.5400
Dividend Ex-Date 05/14/2014
5 Year Dividend Growth 19.14%
Next Earnings Announcement 08/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RCUS

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for RCUS

Arseus NV provides a wide range of products for the health, wellness, esthetics and ageing populations. The Company distributes and resells dental equipment, medical equipment, pharmaceuticals, and provides integrated information technology solutions for healthcare professionals.

Gerardus Van Jeveren "Ger"Chief Executive OfficerJan PeetersChief Financial Officer
Dirk Van LerbergheCEO:CorilusMario HuygheCEO:Healthcare Solutions
More Company Profile & Key Executives for RCUS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil